BioCentury | Apr 11, 2011
Financial News

Aldagen withdraws IPO

...Aldagen Inc. , Durham, N.C. Business: Gene/Cell therapy Date announced: 4/5/11 Type: IPO Underwriters: Boenning & Scattergood Inc.; Ladenburg...
BioCentury | Jan 31, 2011
Financial News

Iaso Pharma amends IPO

...raised: Up to $23 million Shares: 4 million Price: $4.50-$5.50 Underwriters: Ladenburg Thalmann; Maxim Group; Boenning & Scattergood Inc....
BioCentury | Jul 5, 2010
Financial News

Aldagen amends IPO

...Date announced: 7/2/10 Type: IPO To be raised: Up to $40 million Price: TBD Underwriter: Boenning & Scattergood Inc....
BioCentury | May 24, 2010
Financial News

RegeneRx completes follow-on

...million Units: 11.5 million Price: $0.41 (unit) Shares after offering: 71.9 million Underwriters: Maxim Group; Boenning & Scattergood Inc....
BioCentury | May 10, 2010
Financial News

Aldagen amends IPO

...Date announced: 5/5/10 Type: IPO To be raised: Up to $80.5 million Price: TBD Underwriters: Boenning & Scattergood Inc....
BioCentury | Dec 14, 2009
Financial News

Aldagen amends IPO

...be raised: Up to $80.5 million Price: TBD Shares: TBD Underwriters: Cowen; Wells Fargo; Needham; Boenning & Scattergood Inc....
BioCentury | Feb 16, 2009
Company News

Ambrilia cancer, infectious news

...Ambrilia retained Boenning & Scattergood Inc. to review strategic alternatives. The company also said it has completed its previously...
BioCentury | Oct 27, 2008
Company News

Chemokine Therapeutics cancer, hematology, cardiovascular news

...Chemokine hired Boenning & Scattergood Inc. to evaluate strategic options including merger, sale, licensing and partnership transactions. Chemokine's CTCE-9908...
Items per page:
1 - 8 of 8
BioCentury | Apr 11, 2011
Financial News

Aldagen withdraws IPO

...Aldagen Inc. , Durham, N.C. Business: Gene/Cell therapy Date announced: 4/5/11 Type: IPO Underwriters: Boenning & Scattergood Inc.; Ladenburg...
BioCentury | Jan 31, 2011
Financial News

Iaso Pharma amends IPO

...raised: Up to $23 million Shares: 4 million Price: $4.50-$5.50 Underwriters: Ladenburg Thalmann; Maxim Group; Boenning & Scattergood Inc....
BioCentury | Jul 5, 2010
Financial News

Aldagen amends IPO

...Date announced: 7/2/10 Type: IPO To be raised: Up to $40 million Price: TBD Underwriter: Boenning & Scattergood Inc....
BioCentury | May 24, 2010
Financial News

RegeneRx completes follow-on

...million Units: 11.5 million Price: $0.41 (unit) Shares after offering: 71.9 million Underwriters: Maxim Group; Boenning & Scattergood Inc....
BioCentury | May 10, 2010
Financial News

Aldagen amends IPO

...Date announced: 5/5/10 Type: IPO To be raised: Up to $80.5 million Price: TBD Underwriters: Boenning & Scattergood Inc....
BioCentury | Dec 14, 2009
Financial News

Aldagen amends IPO

...be raised: Up to $80.5 million Price: TBD Shares: TBD Underwriters: Cowen; Wells Fargo; Needham; Boenning & Scattergood Inc....
BioCentury | Feb 16, 2009
Company News

Ambrilia cancer, infectious news

...Ambrilia retained Boenning & Scattergood Inc. to review strategic alternatives. The company also said it has completed its previously...
BioCentury | Oct 27, 2008
Company News

Chemokine Therapeutics cancer, hematology, cardiovascular news

...Chemokine hired Boenning & Scattergood Inc. to evaluate strategic options including merger, sale, licensing and partnership transactions. Chemokine's CTCE-9908...
Items per page:
1 - 8 of 8